|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 7
Zeitschriftenartikel
Dapper, H.; Belka, C.; Bock, F.; Budach, V.; Budach, W.; Christiansen, H.; Debus, J.; Distel, L.; Dunst, J.; Eckert, F.; Eich, H.; Eicheler, W.; Engenhart-Cabillic, R.; Fietkau, R.; Fleischmann, D. F.; Frerker, B.; Giordano, F. A.; Grosu, A. L.; Herfarth, K.; Hildebrandt, G.; Kaul, D.; Koelbl, O.; Krause, M.; Krug, D.; Martin, D.; Matuschek, C.; Medenwald, D.; Nicolay, N. H.; Niewald, M.; Oertel, M.; Petersen, C.; Pohl, F.; Raabe, A.; Roedel, C.; Ruebe, C.; Schmalz, C.; Schmeel, L. C.; Steinmann, D.; Stueben, G.; Thamm, R.; Vordermark, D.; Vorwerk, H.; Wiegel, T.; Zips, D. und Combs, S. E.
(2021):
Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO).
In: Strahlentherapie und Onkologie, Bd. 198, Nr. 1: S. 1-11
Ostheimer, C.; Maeurer, M.; Ebert, N.; Schmitt, D.; Krug, D.; Baumann, R.; Henkenberens, C.; Giordano, F. A.; Sautter, L.; Lopez, Guerra; Fleischmann, D. F.; Niyazi, M.; Kasmann, L.; Kaul, D.; Thieme, A. H.; Billiet, C.; Dobiasch, S.; Arnold, C. R.; Oertel, M.; Haussmann, J.; Gauer, T.; Goy, Y.; Suess, C.; Ziegler, S.; Panje, C. M.; Baues, C.; Trommer-Nestler, M.; Skripcak, T. und Medenwald, D.
(2021):
Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group.
In: Strahlentherapie und Onkologie, Bd. 197, Nr. 5: S. 385-395
Oertel, M.; Linde, P.; Maeurer, M.; Fleischmann, D. F.; Dietzel, C. T. und Krug, D.
(2020):
Quality of teaching radiation oncology in Germany-where do we stand? Results from a 2019 survey performed by the working group "young DEGRO" of the German Society of Radiation Oncology.
In: Strahlentherapie und Onkologie, Bd. 196, Nr. 8: S. 699-704
Unterrainer, M.; Fleischmann, D. F.; Vettermann, F.; Ruf, V.; Kaiser, L.; Nelwan, D.; Lindner, S.; Brendel, M.; Wenter, V.; Stoecklein, S.; Herms, J.; Milenkovic, V. M.; Rupprecht, R.; Tonn, J. C.; Belka, Claus 
ORCID: https://orcid.org/0000-0002-1287-7825; Bartenstein, Peter; Niyazi, Maximilian und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2020):
TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative F-18-GE-180 PET study.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 47, Nr. 6: S. 1368-1380
ORCID: https://orcid.org/0000-0002-1287-7825; Bartenstein, Peter; Niyazi, Maximilian und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2020):
TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative F-18-GE-180 PET study.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 47, Nr. 6: S. 1368-1380
Bodensohn, R.; Hadi, I; Fleischmann, D. F.; Corradini, S.; Thon, N.; Rauch, J.; Belka, C. und Niyazi, M.
(2019):
Bevacizumab as a treatment option for radiation necrosis after cranial radiation therapy: a retrospective monocentric analysis.
In: Strahlentherapie und Onkologie, Bd. 196, Nr. 1: S. 70-76
Unterrainer, Marcus; Fleischmann, D. F.; Diekmann, C.; Vomacka, L.; Lindner, S.; Vettermann, F.; Brendel, M.; Wenter, V.; Ertl-Wagner, B.; Herms, J.; Wetzel, C.; Rupprecht, R.; Tonn, J. C.; Belka, C.; Bartenstein, P.; Niyazi, M. und Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Comparison of F-18-GE-180 and dynamic F-18-FET PET in high grade glioma: a double-tracer pilot study.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 46, Nr. 3: S. 580-590
ORCID: https://orcid.org/0000-0003-0953-7624
(2019):
Comparison of F-18-GE-180 and dynamic F-18-FET PET in high grade glioma: a double-tracer pilot study.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 46, Nr. 3: S. 580-590
Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Unterrainer, M.; Fleischmann, D. F.; Lindner, S.; Vettermann, F.; Brunegraf, A.; Vomacka, L.; Brendel, M.; Wenter, V.; Wetzel, C.; Rupprecht, R.; Tonn, J.-C.; Belka, C.; Bartenstein, P. und Niyazi, M.
(2017):
TSPO PET for glioma imaging using the novel ligand F-18-GE-180: first results in patients with glioblastoma.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 44, Nr. 13: S. 2230-2238
ORCID: https://orcid.org/0000-0003-0953-7624; Unterrainer, M.; Fleischmann, D. F.; Lindner, S.; Vettermann, F.; Brunegraf, A.; Vomacka, L.; Brendel, M.; Wenter, V.; Wetzel, C.; Rupprecht, R.; Tonn, J.-C.; Belka, C.; Bartenstein, P. und Niyazi, M.
(2017):
TSPO PET for glioma imaging using the novel ligand F-18-GE-180: first results in patients with glioblastoma.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 44, Nr. 13: S. 2230-2238